Search

Olga Antipova Phones & Addresses

  • Naperville, IL
  • Chicago, IL
  • Darien, IL
  • Downers Grove, IL

Resumes

Resumes

Olga Antipova Photo 1

Research Associate

View page
Location:
10 west 33Rd St, Chicago, IL 60616
Industry:
Biotechnology
Work:
Illinois Institute of Technology
Research Associate
Skills:
Software Quality Assurance
Russian
Olga Antipova Photo 2

Research Associate At Illinois Institute Of Technology

View page
Position:
Research Associate at Illinois Institute of Technology
Location:
Greater Chicago Area
Industry:
Biotechnology
Work:
Illinois Institute of Technology
Research Associate

Publications

Us Patents

Thin Fibril Collagen Material And Method For Making Thin Fibril Collagen From Native Collagen Fibers

View page
US Patent:
20100255457, Oct 7, 2010
Filed:
Apr 7, 2009
Appl. No.:
12/419689
Inventors:
Joseph Orgel - Wadsworth IL, US
Olga Antipova - Darien IL, US
International Classification:
A01N 1/02
C07K 14/78
US Classification:
435 11, 530356
Abstract:
A collagen material having a form of thin fibrils generally free of fibril-bundling proteogylcan interactions, and a method for providing the thin fibril collagen material from native collagen fibers. The method uses proteoglycan antibodies to disassociate the proteoglycan interactions in bundled collagen fibrils to provide the constituent fibrils. The process can be used as a model for arthritis and the resulting fibrils can be used to form new extracellular matrix biomaterials and new tissues.

Method For Obtaining Thin Fibril Collagen By Contacting Native Collagen With An Antibody

View page
US Patent:
20160368968, Dec 22, 2016
Filed:
Sep 6, 2016
Appl. No.:
15/257089
Inventors:
- Northbrook IL, US
Olga Antipova - Naperville IL, US
International Classification:
C07K 14/78
G01N 33/68
C07K 1/14
A61L 27/24
Abstract:
A collagen material having a form of thin fibrils generally free of fibril-bundling proteogylcan interactions, and a method for providing the thin fibril collagen material from native collagen fibers. The method uses proteoglycan antibodies to disassociate the proteoglycan interactions in bundled collagen fibrils to provide the constituent fibrils. The process can be used as a model for arthritis and the resulting fibrils can be used to form new extracellular matrix biomaterials and new tissues.
Olga A Antipova from Naperville, IL, age ~43 Get Report